USA: A vaccine producer who had to discard 15 million doses of J&J now must discard 60 million.

USA%3A%20A%20vaccine%20producer%20who%20had%20to%20discard%2015%20million%20doses%20of%20J%26J%20now%20must%20discard%2060%20million.
source: nytimes.com

These are inoculants manufactured in a Maryland plant where, by mistake, it was contaminated at the doses with activities necessary to create the AstraZeneca vaccine.

The FDA (Federal Food and Drug Administration) has ordered the Johnson & Johnson laboratory to eliminate 60 million doses of the vaccine they developed against COVID-19, which requires a single dose, manufactured by a plant in Baltimore, in the state of Maryland, which has had problems with its production line.

It is a plant owned by Emergent BioSolutions. In March of this year, the FDA ordered Emergent to stop producing vaccines for Johnson & Johnson and AstraZeneca after one of its plants inadvertently contaminated 15 million doses of J&J with an asset needed to develop AstraZeneca vaccine doses. Since then, millions of doses of both vaccines have been in limbo, waiting to be approved for use.

After three months of investigations, the FDA determined that it was not safe for these doses to be placed in humans. Therefore it has emerged that now Johnson & Johnson will have to get rid of 60 million vaccines because they could be altered. The number of doses of the AstraZeneca vaccine that are missed by this error is unknown. The vaccine was being produced for export as the AstraZeneca vaccine has not yet been approved in the United States.

While the details of the error that led to the contamination of all these vaccines are unknown, it is known that it was a human failure.

The investigation found a consignment of 10 million doses of the Johnson & Johnson vaccine that were in good condition. The company is authorized to use them immediately.

These 10 million doses will be part of the vaccines that the United States sends abroad, as part of the international aid plan announced by President Joe Biden. In the United States, the demand for vaccines is declining. The country has pledged to help other nations with a shortage of vaccines.

So far, more than 9 million people have been inoculated in the country with the vaccine developed by Johnson & Johnson, which in addition to having these problems in one of the manufacturing plants, was suspended for a couple of weeks for six cases of clots developed in young women after receiving their dose.

Health authorities have stated on several occasions that it is absolutely safe to receive the Johnson & Johnson mono dose; however, some still have mistrust when receiving it.

So far, a total of 306 million doses of the COVID-19 vaccine have been administered in the United States, with 142 million people having full immunization. The vast majority of Americans received vaccines from Pfizer and Moderna, which require two doses.

The goal as a nation is to have 70% of the population with at least one dose given on July 4, the homeland date chosen by President Biden to mark the beginning of the end of the pandemic. As the date approaches, it is difficult to believe that the goal will be reached. In less than a month, just over 50% of the population has received part of their immunization.

Access to vaccines has little to do with how difficult it is to reach Biden's goal since, in the United States, everyone over 12 years of age can be vaccinated. But there is a sector of the population that still resists being inoculated.

Starting next Monday, a group of senior officials led by Vice President Kamala Harris, seconded by her husband and the first lady, Jill Biden, will go out to tour the country for a week as an incentive so that those who have not yet been vaccinated, are come closer to inoculate.